Risk of Second Primary Cancer in People with Non-melanoma Skin Cancer: A Nationwide Cohort Study

Overview

Journal Cancer Res Treat

Specialty Oncology

Date 2017 May 12

PMID 28494532

Authors

Shu-Hui Wang

Ching-Chi Chi

Zi-Hao Zhao

Tao-Hsin Tung

Affiliations

Soon will be listed here.

Abstract

Purpose: Previous western studies have found Caucasians with skin cancer, either melanoma or nonmelanoma skin cancer (NMSC), have an elevated risk of second primary cancer. Our objective was to assess the risk of second primary cancer in Taiwanese with NMSC.

Materials And Methods: By using data from Taiwan's National Health Insurance Research Database, we conducted a population-based cohort study to assess the risk of incident second primary cancer in Taiwanese affected by NMSC.

Results: We identified 505 subjects with NMSC and 2,020 matched controls. After adjustment for potential confounders including age, sex, urbanization, and Charlson Comorbidity Index, people who had NMSC had a 1.43-fold (95% confidence interval [CI], 1.05 to 1.96) risk for the development of second primary cancer as comparedwith control group. Menwith NMSC had a 2.99-fold (95% CI, 1.00 to 9.10) risk for second primary cancer involving the lip, oral cavity, and pharynx and a 3.51-fold (95% CI, 1.21 to 10.17) risk for second primary cancer involving the genitourinary organs when compared to the control group. By contrast, women with NMSC did not have an increased risk of second primary cancer.

Conclusion: This study revealed Asians with NMSC have an increased risk of second primary cancer. Our findings can be a useful reference for health care for people diagnosed with NMSC.

References

DAgostino Jr R . Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998; 17(19):2265-81. DOI: 10.1002/(sici)1097-0258(19981015)17:19<2265::aid-sim918>3.0.co;2-b. View

Efird J, Friedman G, Habel L, Tekawa I, Nelson L . Risk of subsequent cancer following invasive or in situ squamous cell skin cancer. Ann Epidemiol. 2002; 12(7):469-75. DOI: 10.1016/s1047-2797(01)00276-9. View

Soerjomataram I, Louwman W, Lemmens V, Coebergh J, de Vries E . Are patients with skin cancer at lower risk of developing colorectal or breast cancer?. Am J Epidemiol. 2008; 167(12):1421-9. DOI: 10.1093/aje/kwn077. View

Chuang S, Hashibe M, Scelo G, Brewster D, Pukkala E, Friis S . Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries. Cancer Epidemiol Biomarkers Prev. 2008; 17(6):1543-9. DOI: 10.1158/1055-9965.EPI-07-2876. View

Hwang C, Chen Y, Lin M, Chen T, Chu S, Chen C . Elevated risk of second primary cancer in patients with cutaneous malignant melanoma: a nationwide cohort study in Taiwan. J Dermatol Sci. 2010; 60(3):167-72. DOI: 10.1016/j.jdermsci.2010.10.004. View

Zeegers M, Tan F, Verhagen A, Weijenberg M, van den Brandt P . Elevated risk of cancer of the urinary tract for alcohol drinkers: a meta-analysis. Cancer Causes Control. 1999; 10(5):445-51. DOI: 10.1023/a:1008938520686. View

Song F, Qureshi A, Giovannucci E, Fuchs C, Chen W, Stampfer M . Risk of a second primary cancer after non-melanoma skin cancer in white men and women: a prospective cohort study. PLoS Med. 2013; 10(4):e1001433. PMC: 3635863. DOI: 10.1371/journal.pmed.1001433. View

Levi F, Randimbison L, Te V, Maspoli Conconi M, La Vecchia C . Risk of prostate, breast and colorectal cancer after skin cancer diagnosis. Int J Cancer. 2008; 123(12):2899-901. DOI: 10.1002/ijc.23816. View

Charlson M, Pompei P, Ales K, MacKenzie C . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373-83. DOI: 10.1016/0021-9681(87)90171-8. View

10.

Jung G, Dover D, Salopek T . Risk of second primary malignancies following a diagnosis of cutaneous malignant melanoma or nonmelanoma skin cancer in Alberta, Canada from 1979 to 2009. Br J Dermatol. 2014; 170(1):136-43. DOI: 10.1111/bjd.12694. View

11.

Chuang Y, Chuang K . Gender differences in relationships between social capital and individual smoking and drinking behavior in Taiwan. Soc Sci Med. 2008; 67(8):1321-30. DOI: 10.1016/j.socscimed.2008.06.033. View

12.

Jemal A, Center M, DeSantis C, Ward E . Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010; 19(8):1893-907. DOI: 10.1158/1055-9965.EPI-10-0437. View

13.

Chuang S, Scelo G, Tonita J, Tamaro S, Jonasson J, Kliewer E . Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries. Int J Cancer. 2008; 123(10):2390-6. DOI: 10.1002/ijc.23798. View

14.

Bower C, Lear J, Bygrave S, ETHERINGTON D, Harvey I, Archer C . Basal cell carcinoma and risk of subsequent malignancies: A cancer registry-based study in southwest England. J Am Acad Dermatol. 2000; 42(6):988-91. View

15.

Hsing A, Ioannidis J . Nationwide Population Science: Lessons From the Taiwan National Health Insurance Research Database. JAMA Intern Med. 2015; 175(9):1527-9. DOI: 10.1001/jamainternmed.2015.3540. View

16.

Li B, Evans D, Faris P, Dean S, Quan H . Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases. BMC Health Serv Res. 2008; 8:12. PMC: 2267188. DOI: 10.1186/1472-6963-8-12. View

17.

Robsahm T, Karagas M, Rees J, Syse A . New malignancies after squamous cell carcinoma and melanomas: a population-based study from Norway. BMC Cancer. 2014; 14:210. PMC: 3994878. DOI: 10.1186/1471-2407-14-210. View

18.

Rosenberg C, Greenland P, Khandekar J, Loar A, Ascensao J, Lopez A . Association of nonmelanoma skin cancer with second malignancy. Cancer. 2003; 100(1):130-8. DOI: 10.1002/cncr.11874. View

19.

Satagopan J, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach A . A note on competing risks in survival data analysis. Br J Cancer. 2004; 91(7):1229-35. PMC: 2410013. DOI: 10.1038/sj.bjc.6602102. View

20.

Wu C, Lai M, Gau S, Wang S, Tsai H . Concordance between patient self-reports and claims data on clinical diagnoses, medication use, and health system utilization in Taiwan. PLoS One. 2014; 9(12):e112257. PMC: 4251897. DOI: 10.1371/journal.pone.0112257. View